Avant BIO
New York, New York, United States · Series B
Their stated focus (public profile)
AVANT BIO invests in life sciences companies at the intersection of advanced technologies and novel therapeutics, focusing on Therapeutic Enabling Technologies, Biomanufacturing Tools, Automation, Machine Learning and AI Applications, Healthtech, Techbio, and Contract Services. The fund partners with visionary entrepreneurs to advance transformative therapies, leveraging over 40 years of combined experience to identify high-potential companies. AVANT BIO aims to capitalize on the convergence of biology and technology to unlock value in innovative life sciences companies.
Stages: Series B
Sectors: Robotics, Healthtech, Life sciences
On file: 5 companies on record
Website: avant.bio
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.